Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts
Siri H. Strand(Aarhus University Hospital), Graham A. Colditz(Jewish Hospital), Julie R. Nangia(Unknown), Magdalena Matusiak(Stanford University), Jen Tappenden(Washington University in St. Louis), Kornélia Polyák(Dana-Farber Cancer Institute), Dadong Zhang(Precision for Medicine (United States)), José A. Seoane(Stanford University), Fergus J. Couch(Mayo Clinic), Lunden Simpson(Duke University), Belén Rivero‐Gutiérrez(Stanford University), Katherine DeSchryver(Washington University in St. Louis), Alastair M. Thompson(Baylor College of Medicine), Kouros Owzar(Duke University), Jeffrey R. Marks(Duke Medical Center), Christina Curtis(Chan Zuckerberg Initiative (United States)), Jingqin Luo(Washington University in St. Louis), Bryan Harmon(Montefiore Medical Center), Lorraine King(Duke University), Aziz Khan(Stanford University), Shu Jiang(Washington University in St. Louis), Anna Maria Storniolo(Indiana University Health), Lauren Anderson(Duke University), Timothy Hardman(Duke University), Robyn Burns(Breast Cancer Research Foundation), Mark Kilgore(University of Washington), Luis Cisneros(Arizona State University), Carlo C. Maley(Biocom), Chunfang Zhu(Stanford University), Sujay Vennam(Stanford University), Wei Shi(Affiliated Hospital of Shandong University of Traditional Chinese Medicine), Priscilla F. McAuliffe(University of Pittsburgh), Tari A. King(Brigham and Women's Hospital), Sushama Varma(Stanford University), Shirley Zhu(Stanford Medicine), Cody Straub(Duke University), Tyler Risom(Stanford University), Kathleen E. Houlahan(Stanford University), Kristalyn K. Gallagher(University of North Carolina at Chapel Hill), Jason Wang(Stanford University), Jennifer F. Tseng(Boston University), Joanna Lee(The University of Texas MD Anderson Cancer Center), Allison Hall(Duke Medical Center), Sucheta Srivastava(Stanford University), Rob Tibshirani(Stanford University), Gaorav P. Gupta(University of North Carolina at Chapel Hill), Daisy Yi Ding(Stanford University), Deborah J. Veis(Washington University in St. Louis), Angela DeMichele(University of Pennsylvania)
Cited by 88
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k